High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy.

Detalles Bibliográficos
Publicado en:	Breast Cancer Research Vol. 27; no. 1; pp. 1 - 13
Autores principales:	Parissenti, Amadeo M., Pritzker, Laura B., Dahle, Maria Aanesland, Gythfeldt, Hedda von der Lippe, Masilamani, Twinkle, Theriault, Gabriel, St-Onge, Renée, D'costa, Lavina, Lingjaerde, Ole Christian, Haugen, Mads Haugland, Engebraaten, Olav
Formato:	Journal Article
Publicado:	BioMed Central 8/11/2025
Acceso en línea:	Ver este registro en EBSCOhost

Descripción
Descripción no disponible.